Fabian Gerlinghaus, CEO

Oct. 12 | 11:30am | Ecolab Life Sciences Ballroom 

South San Francisco, CA


Cellares is creating the future of cell therapy manufacturing and accelerating access to life-saving cell therapies. The company is developing a one-of-a-kind solution to overcome the limitations associated with manufacturing cell therapies that makes them affordable and widely available to patients in need. With Cellares’ proprietary platform—the Cell Shuttle—the cell therapy industry will no longer have to compromise by either choosing a manufacturing platform that is semi-automated but lacks workflow flexibility, or one that provides customization but not the end-to-end automation needed to manufacture at scale.


By using this website you agree to accept our Privacy Policy and Terms & Conditions